SCHEMBL304602

SCHEMBL304602

CC(=O)CC(=O)OC(CC(=O)O)(CC(=O)O)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
TSHR P16473 2/20 0.37
CYP2C19 P33261 2/20 0.37
HIF1A Q16665 2/20 0.37
CYP2D6 P10635 1/20 0.37
KDM4E B2RXH2 1/20 0.34
KDM6B O15054 1/20 0.34
KDM5C P41229 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
PHF8 Q9UPP1 1/20 0.34
KDM2A Q9Y2K7 1/20 0.34
ALDH1A1 P00352 1/20 0.33
HMGCR P04035 1/20 0.33
CHRM1 P11229 1/20 0.33
TBXA2R P21731 1/20 0.33
ADRA1A P35348 1/20 0.33
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8741818 0.87 ALDH1A1 (0.39) TSHRCYP2C19HIF1ACYP2D6ALDH1A1
SCHEMBL16393918 0.85 ALDH1A1 (0.37) TSHRCYP2C19HIF1ACYP2D6ALDH1A1
SCHEMBL673750 0.85 ALDH1A1 (0.37) TSHRCYP2C19HIF1ACYP2D6ALDH1A1
SCHEMBL2768230 0.81 CYP2D6 (0.34) MGAMGAASIMGAM2TSHR
SCHEMBL712972 0.79 GLRA1 (0.38) TSHRCYP2C19HIF1ACYP2D6KDM4E
SCHEMBL1870019 0.79 CYP2C19 (0.39) TSHRCYP2C19HIF1ACYP2D6KDM4E
SCHEMBL284431 0.79 CYP2C19 (0.42) GAATSHRCYP2C19HIF1ACYP2D6
SCHEMBL1989298 0.79 ALDH1A1 (0.39) TSHRCYP2C19HIF1ACYP2D6KDM6B
SCHEMBL23529158 0.78 GLRA1 (0.36) TSHRCYP2C19HIF1ACYP2D6KDM4E
SCHEMBL23529122 0.78 GLRA1 (0.36) TSHRCYP2C19HIF1ACYP2D6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200268940-A1 LIQUID PLATELET-RICH FIBRIN AS A CARRIER SYSTEM FOR BIOMATERIALS AND BIOMOLECULES MIRON RICHARD J (US) 2020-08-27 US disclosed
EP-3041928-B1 COMPOSITIONS COMPRISING A MITOFUSIN INHIBITOR FOR PROMOTING CELL REPROGRAMMING AND A USE THEREOF KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) 2020-03-25 EP disclosed
EP-3624830-A1 LIQUID PLATELET-RICH FIBRIN AS A CARRIER SYSTEM FOR BIOMATERIALS AND BIOMOLECULES Miron, Richard J. (US) 2020-03-25 EP disclosed
US-10494611-B2 Compositions comprising a mitofusin inhibitor for promoting cell reprogramming and a use thereof KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLGY (KR) 2019-12-03 US disclosed
WO-2018212758-A1 LIQUID PLATELET-RICH FIBRIN AS A CARRIER SYSTEM FOR BIOMATERIALS AND BIOMOLECULES MIRON RICHARD J (US) 2018-11-22 WO disclosed
EP-2551342-B1 METHOD FOR DIFFERENTIATING CARTILAGE CELLS, BONE CELLS, NERVE CELLS OR FAT CELLS FROM HUMAN INFERIOR TURBINATE MESENCHYMAL STROMAL CELLS CATHOLIC UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION (KR) 2018-05-02 EP disclosed
WO-2017203331-A1 COMPOSITION AND METHODS FOR BONE TISSUE ENGINEERING Universität Bern (CH) 2017-11-30 WO disclosed
US-9650663-B2 Sensor for detecting stem cell differentiation based on electrochemical methods Industry-University Cooperation Foundation Sogang University (KR) 2017-05-16 US disclosed
US-20170051254-A1 COMPOSITIONS COMPRISING A MITOFUSIN INHIBITOR FOR PROMOTING CELL REPROGRAMMING AND A USE THEREOF KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2017-02-23 US disclosed
US-9476064-B2 Neuro-progenitor produced from an SCNT-derived ES cell H BION CO., LTD. (KR) 2016-10-25 US disclosed
WO-2000033865-A9 METHODS OF INHIBITING ECTOPIC CALCIFICATION UNIV WASHINGTON (US) 2002-08-22 WO disclosed
US-20020032157-A1 METHODS OF INHIBITING ECTOPIC CALCIFICATION NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2002-03-14 US disclosed
EP-1135155-A1 METHODS OF INHIBITING ECTOPIC CALCIFICATION University of Washington (US) 2001-09-26 EP disclosed
EP-1123097-A1 PHARMACEUTICAL COMPOSITION CONTAINING DECURSIN Chong, Se Young (KR) 2001-08-16 EP disclosed
WO-2000033865-A1 METHODS OF INHIBITING ECTOPIC CALCIFICATION UNIVERSITY OF WASHINGTON (US) 2000-06-15 WO disclosed
WO-2000023074-A1 PHARMACEUTICAL COMPOSITION CONTAINING DECURSIN BINEX CO., LTD. (KR) 2000-04-27 WO disclosed
US-5962404-A CENTRAL NERVOUS SYSTEM DISORDERS YEDA RESEARCH & DEVELOPMENT CO., LTD. (IL) 1999-10-05 US disclosed
EP-0415321-B1 Oligodendrocyte cytotoxic factor YEDA RES & DEV (IL) 1995-11-08 EP disclosed
US-5106731-A Kit for cancer diagnosis THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1992-04-21 US disclosed
EP-0415321-A1 Oligodendrocyte cytotoxic factor YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) 1991-03-06 EP disclosed